(Q46802991)

25 December 2017

title

Losing inhibition with ketamine (English)

1 reference

25 December 2017

author name string

Jeremy Seamans

series ordinal

1

1 reference

25 December 2017

publication date

1 February 2008

1 reference

25 December 2017

published in

Nature Chemical Biology

1 reference

25 December 2017

volume

4

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

91-93

1 reference

25 December 2017

Bringing order to the glutamate chaos in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Free radical pathology and antioxidant defense in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Oxidative reactions and schizophrenia: a review-discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0208-91

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCHEMBIO0208-91

1 reference

25 December 2017

1 reference

25 December 2017